Rapidly expanding knowledge of the role of genetic mutations such as NPM1 in the development of such an aggressive and difficult to treat disease like AML has led to more accurate prognoses and several potential treatment options where there has been few before, particularly for elderly patients. Here, NPM1 is linked to acute myeloid leukemia.